Physician

Bassam A Assaf, MD

According to 2025 Medicare claims, Bassam Assaf, MD (NPI: 1225009426) practices neurology in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Rock Island, IL. This provider's primary affiliated billing organization is THE CENTER FOR NEUROSCIENCES, LLC (NPI: 1386889277; TIN: 263802899) and primary practice location at 61265-6867. Assaf is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Assaf's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 705 traditional Medicare patients, billed 2,539 HCPCS/CPT codes, and received $242,905 in Medicare payments. The top billing code was 95819 (Measurement of brain wave activity (eeg), awake and asleep). Part D data shows 3,999 prescription claims across 671 beneficiaries totaling $721,576 in drug costs, led by Ubrelvy (Ubrogepant). DME data shows 780 claims. Open Payments data shows 180 records totaling $3,709. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $936,071 to $721,576. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $58,188 to $30,312.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	831	2,764	$290,347
2016	768	2,612	$270,640
2017	676	1,939	$226,223
2018	692	1,849	$197,186
2019	582	1,694	$221,194
2020	778	2,323	$244,749
2021	739	2,075	$238,090
2022	677	1,932	$218,089
2023	694	2,054	$240,641
2024	705	2,539	$242,905

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	414	3,551	$936,071
2016	441	3,952	$963,295
2017	452	3,896	$961,161
2018	461	4,292	$1,003,589
2019	446	3,721	$880,415
2020	543	4,616	$884,962
2021	596	3,426	$933,678
2022	547	3,146	$802,884
2023	525	2,935	$535,402
2024	671	3,999	$721,576

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	362	787	$57,644
2016	282	663	$22,213
2017	309	572	$12,817
2018	300	598	$15,692
2019	282	595	$15,680
2020	278	560	$17,757
2021	298	602	$22,256
2022	366	684	$27,343
2023	345	833	$39,311
2024	333	780	$28,889

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95819	Measurement of brain wave activity (eeg), awake and asleep	113	114	$284
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	234	234	$164
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	119	170	$131
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	494	902	$88
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	400	644	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ubrelvy	Ubrogepant	69	2,038	$93,715
Nurtec Odt	Rimegepant Sulfate	34	1,043	$67,894
Qulipta	Atogepant	49	1,800	$64,545
Rytary	Carbidopa/Levodopa	40	1,748	$53,112
Xcopri	Cenobamate	43	1,196	$47,972

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	30	178	$5,297
A7031	Face mask interface, replacement for full face mask, each	N	31	67	$5,037
A7030	Full face mask used with positive airway pressure device, each	N	33	58	$4,754
A7032	Cushion for use on nasal mask interface, replacement only, each	N	15	35	$3,474
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	27	59	$2,977

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	180	$3,709	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bassam A. Assaf, MD?

Tedicare shows public-source Medicare data for Bassam A. Assaf, MD (NPI 1225009426), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bassam A. Assaf, MD have ACO affiliation data?

Bassam A. Assaf, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Bassam A. Assaf, MD?

Bassam A. Assaf, MD is linked to THE CENTER FOR NEUROSCIENCES, LLC (billing NPI 1386889277) in the available physician profile data.

Does Bassam A. Assaf, MD have Open Payments data?

Bassam A. Assaf, MD has 180 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.